SLNO logo

Soleno Therapeutics, Inc. (SLNO) Accounts Payable

Annual Accounts Payable:

$8.88M+$5.73M(+182.06%)
December 31, 2024

Summary

  • As of today, SLNO annual accounts payable is $8.88 million, with the most recent change of +$5.73 million (+182.06%) on December 31, 2024.
  • During the last 3 years, SLNO annual accounts payable has risen by +$5.63 million (+172.96%).
  • SLNO annual accounts payable is now at all-time high.

Performance

SLNO Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLNObalance sheet metrics

Quarterly Accounts Payable:

$6.22M+$733.00K(+13.37%)
June 30, 2025

Summary

  • As of today, SLNO quarterly accounts payable is $6.22 million, with the most recent change of +$733.00 thousand (+13.37%) on June 30, 2025.
  • Over the past year, SLNO quarterly accounts payable has increased by +$2.50 million (+67.28%).
  • SLNO quarterly accounts payable is now -30.02% below its all-time high of $8.88 million, reached on December 31, 2024.

Performance

SLNO Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLNObalance sheet metrics

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

SLNO Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+182.1%+67.3%
3Y3 Years+173.0%+158.3%
5Y5 Years+345.2%+70.0%

SLNO Accounts Payable Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+399.8%-30.0%+249.8%
5Y5-Yearat high+399.8%-30.0%+249.8%
All-TimeAll-Timeat high>+9999.0%-30.0%>+9999.0%

SLNO Accounts Payable History

DateAnnualQuarterly
Jun 2025
-
$6.22M(+13.4%)
Mar 2025
-
$5.48M(-38.3%)
Dec 2024
$8.88M(+182.1%)
$8.88M(+42.3%)
Sep 2024
-
$6.24M(+68.0%)
Jun 2024
-
$3.72M(-53.7%)
Mar 2024
-
$8.02M(+154.7%)
Dec 2023
$3.15M(+77.2%)
$3.15M(-2.1%)
Sep 2023
-
$3.22M(-6.6%)
Jun 2023
-
$3.44M(+23.9%)
Mar 2023
-
$2.78M(+56.3%)
Dec 2022
$1.78M(-45.4%)
$1.78M(-23.5%)
Sep 2022
-
$2.32M(-3.4%)
Jun 2022
-
$2.41M(-0.2%)
Mar 2022
-
$2.41M(-25.9%)
Dec 2021
$3.25M(-6.7%)
$3.25M(-15.7%)
Sep 2021
-
$3.86M(+15.2%)
Jun 2021
-
$3.35M(-28.3%)
Mar 2021
-
$4.67M(+33.8%)
Dec 2020
$3.49M(+74.9%)
$3.49M(+8.6%)
Sep 2020
-
$3.21M(-12.1%)
Jun 2020
-
$3.66M(+5.1%)
Mar 2020
-
$3.48M(+74.4%)
Dec 2019
$2.00M
$2.00M(+15.0%)
DateAnnualQuarterly
Sep 2019
-
$1.74M(-0.3%)
Jun 2019
-
$1.74M(+38.3%)
Mar 2019
-
$1.26M(+34.7%)
Dec 2018
$934.00K(+47.6%)
$934.00K(-25.0%)
Sep 2018
-
$1.25M(+26.9%)
Jun 2018
-
$981.00K(-13.4%)
Mar 2018
-
$1.13M(+79.0%)
Dec 2017
$633.00K(+54.2%)
$633.00K(-1.4%)
Sep 2017
-
$642.00K(-37.6%)
Jun 2017
-
$1.03M(+10.1%)
Mar 2017
-
$935.00K(+73.8%)
Dec 2016
$410.50K(-40.9%)
$537.90K(-37.6%)
Sep 2016
-
$862.00K(-9.9%)
Jun 2016
-
$957.00K(-24.2%)
Mar 2016
-
$1.26M(+81.6%)
Dec 2015
$695.10K(-29.6%)
$695.10K(-27.1%)
Sep 2015
-
$953.00K(-3.6%)
Jun 2015
-
$989.00K(+59.3%)
Mar 2015
-
$621.00K(-37.1%)
Dec 2014
$986.80K(+1610.2%)
$986.80K(-20.3%)
Sep 2014
-
$1.24M(+1294.1%)
Mar 2014
-
$88.80K(+53.9%)
Dec 2013
$57.70K(-73.7%)
$57.70K
Dec 2012
$219.50K
-

FAQ

  • What is Soleno Therapeutics, Inc. annual accounts payable?
  • What is the all-time high annual accounts payable for Soleno Therapeutics, Inc.?
  • What is Soleno Therapeutics, Inc. annual accounts payable year-on-year change?
  • What is Soleno Therapeutics, Inc. quarterly accounts payable?
  • What is the all-time high quarterly accounts payable for Soleno Therapeutics, Inc.?
  • What is Soleno Therapeutics, Inc. quarterly accounts payable year-on-year change?

What is Soleno Therapeutics, Inc. annual accounts payable?

The current annual accounts payable of SLNO is $8.88M

What is the all-time high annual accounts payable for Soleno Therapeutics, Inc.?

Soleno Therapeutics, Inc. all-time high annual accounts payable is $8.88M

What is Soleno Therapeutics, Inc. annual accounts payable year-on-year change?

Over the past year, SLNO annual accounts payable has changed by +$5.73M (+182.06%)

What is Soleno Therapeutics, Inc. quarterly accounts payable?

The current quarterly accounts payable of SLNO is $6.22M

What is the all-time high quarterly accounts payable for Soleno Therapeutics, Inc.?

Soleno Therapeutics, Inc. all-time high quarterly accounts payable is $8.88M

What is Soleno Therapeutics, Inc. quarterly accounts payable year-on-year change?

Over the past year, SLNO quarterly accounts payable has changed by +$2.50M (+67.28%)
On this page